91 related articles for article (PubMed ID: 8401323)
1. Effects of insulin on TGF-beta 1-induced cell growth inhibition in the human hepatoma cell lines.
Hung WC; Chuang LY; Tsai JH; Chang CC
Biochem Mol Biol Int; 1993 Jul; 30(4):655-63. PubMed ID: 8401323
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1.
Hashimoto O; Ueno T; Kimura R; Ohtsubo M; Nakamura T; Koga H; Torimura T; Uchida S; Yamashita K; Sata M
Mol Carcinog; 2003 Apr; 36(4):171-82. PubMed ID: 12669309
[TBL] [Abstract][Full Text] [Related]
3. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
[TBL] [Abstract][Full Text] [Related]
5. Effects of epidermal growth factor on growth control and signal transduction pathways in different human hepatoma cell lines.
Hung WC; Chuang LY; Tsai JH; Chang CC
Biochem Mol Biol Int; 1993 Jun; 30(2):319-28. PubMed ID: 8395924
[TBL] [Abstract][Full Text] [Related]
6. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis.
Tanaka S; Wands JR
Cancer Res; 1996 Aug; 56(15):3391-4. PubMed ID: 8758899
[TBL] [Abstract][Full Text] [Related]
8. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1.
Lin JK; Chou CK
Cancer Res; 1992 Jan; 52(2):385-8. PubMed ID: 1309441
[TBL] [Abstract][Full Text] [Related]
9. Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin.
Chou CK; Ho LT; Ting LP; Hu CP; Su TS; Chang WC; Suen CS; Huang MY; Chang CM
J Clin Invest; 1987 Jan; 79(1):175-8. PubMed ID: 2878937
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle-dependent inhibition of p34cdc2 synthesis by transforming growth factor beta 1 in cycling epithelial cells.
Eblen ST; Fautsch MP; Burnette RJ; Joshi P; Leof EB
Cell Growth Differ; 1994 Feb; 5(2):109-16. PubMed ID: 8180123
[TBL] [Abstract][Full Text] [Related]
11. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Krasagakis K; Garbe C; Schrier PI; Orfanos CE
Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682
[TBL] [Abstract][Full Text] [Related]
12. Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta.
Yen CC; Huang YH; Liao CY; Liao CJ; Cheng WL; Chen WJ; Lin KH
J Mol Endocrinol; 2006 Feb; 36(1):9-21. PubMed ID: 16461923
[TBL] [Abstract][Full Text] [Related]
13. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells.
Suk FM; Chen CH; Lin SY; Cheng CJ; Yen SJ; Hung LF; Liu DZ; Liang YC
Toxicol Lett; 2009 May; 187(1):22-7. PubMed ID: 19429239
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B
Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta 1-mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest.
Reddy KB; Howe PH
J Cell Physiol; 1993 Jul; 156(1):48-55. PubMed ID: 8391008
[TBL] [Abstract][Full Text] [Related]
16. Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: inhibitory actions of vitamin K.
Bouzahzah B; Nishikawa Y; Simon D; Carr BI
J Cell Physiol; 1995 Dec; 165(3):459-67. PubMed ID: 7593224
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
18. Gypenoside induces apoptosis in human Hep3B and HA22T tumour cells.
Chen JC; Chung JG; Chen LD
Cytobios; 1999; 100(393):37-48. PubMed ID: 10643643
[TBL] [Abstract][Full Text] [Related]
19. Vitamin K3 inhibits growth of human hepatoma HepG2 cells by decreasing activities of both p34cdc2 kinase and phosphatase.
Juan CC; Wu FY
Biochem Biophys Res Commun; 1993 Feb; 190(3):907-13. PubMed ID: 8382492
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
